About this episode

This episode discusses the relationship between patient age and the effectiveness of anti-VEGF agents in treating diabetic macular edema.

People in this episode

Host: Jonathan L. Prenner, MD

Topics covered

• diabetic macular edema
• anti-VEGF treatment
• patient age
• ophthalmology
• clinical response

Keywords

• diabetic macular edema
• anti-VEGF
• patient age
• treatment response
• ophthalmology

Mentioned in this episode

Books & works: ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS

More episodes of RETINA Journal Podcasts

• CAN AQUEOUS PROTEOMICS PREDICT THE RECURRENCE OF RHEGMATOGENOUS RETINAL DETACHMENT? · June 22, 2026 · 6 min
• SLEEP DEPRIVATION AND EPIRETINAL MEMBRANE RISK Machine Learning Findings from a Nation-wide Survey · June 15, 2026 · 7 min
• THE "SCOLEX" SIGN A Distinct Hyperreflective Foci on the Wall of Serous Pigment Epithelial Detachments in Central Serous Chorioretinopathy - Micron Report Number Seven · June 2, 2026 · 7 min
• Photobiomodulation in Dry Age-Related Macular Degeneration: Promising Signal, Familiar Questions · May 18, 2026 · 9 min
• LARGE-SIZED HUMAN AMNIOTIC MEMBRANE PATCHING-ASSISTED VITRECTOMY FOR THE MANAGEMENT OF POSTOPERATIVE PROLIFERATIVE VITREORETINOPATHY IN COMPLEX RHEGMATOGENOUS RETINAL DETACHMENTS · May 11, 2026 · 7 min
• IMPACT OF SLEEP APNEA ON RETINAL VEIN OCCLUSION IN INDIVIDUALS 55 AND YOUNGER A Retrospective Cohort Study · April 20, 2026 · 8 min

Explore listener stats, chart rankings, contacts and more on the RETINA Journal Podcasts podcast page.